Matches in Nanopublications for { ?s ?p "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_provenance.
- assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_provenance.
- NP542170.RA9zWxfVEh5t9fjatXdZnVbderzNe-HyK2J4yxGAPfSyk130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542170.RA9zWxfVEh5t9fjatXdZnVbderzNe-HyK2J4yxGAPfSyk130_provenance.
- NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_provenance.
- NP518492.RA6UxW-3sabjnFiZlj4fdnEDe7UH_Z2Ayv0kzvafl9NMY130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518492.RA6UxW-3sabjnFiZlj4fdnEDe7UH_Z2Ayv0kzvafl9NMY130_provenance.